Botha Roelof, an insider at Natera Inc (NTRA), sold 1,154,698 shares of the company on November 23, 2025, at a price of $238.57 per share. The total transaction value reached $275.48 million. Following this sale, Roelof retains 1,154,698 shares of Natera.
Natera, based in Austin, Texas, specializes in genetic testing services and employs 4,424 full-time staff. The company went public on July 2, 2015, and has developed a range of diagnostic solutions, including non-invasive prenatal tests and tumor-specific assays. Natera's market capitalization stands at $32.7 billion, with a trailing twelve-month earnings per share of -2.28.
Insider transactions are reported to the SEC, providing transparency into executives' views on their stock. While selling activity by a single insider can be noteworthy, it should be viewed in the context of broader insider activity and market conditions. Investors are encouraged to analyze trends across multiple insiders and timeframes rather than isolated transactions.
Natera's upcoming earnings report is scheduled for August 5, 2026, with an estimated EPS of -0.54 and revenue forecasted at $637.8 million.